Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Long-Term Investments (2022 - 2023)

Historic Long-Term Investments for Envoy Medical (COCH) over the last 2 years, with Q2 2023 value amounting to $44.6 million.

  • Envoy Medical's Long-Term Investments fell 8951.1% to $44.6 million in Q2 2023 from the same period last year, while for Jun 2023 it was $44.6 million, marking a year-over-year decrease of 8951.1%. This contributed to the annual value of $430.0 million for FY2022, which is N/A changed from last year.
  • Per Envoy Medical's latest filing, its Long-Term Investments stood at $44.6 million for Q2 2023, which was down 8951.1% from $44.4 million recorded in Q1 2023.
  • Envoy Medical's Long-Term Investments' 5-year high stood at $430.0 million during Q4 2022, with a 5-year trough of $44.4 million in Q1 2023.